NRSN – neurosense therapeutics ltd. - ordinary shares (US:NASDAQ)
Stock Stats
News
NeuroSense Therapeutics (NRSN) had its "buy" rating reaffirmed by D. Boral Capital. They now have a $14.00 price target on the stock.
NeuroSense Granted Brazilian Patent Covering PrimeC Composition [Yahoo! Finance]
NeuroSense Granted Brazilian Patent Covering PrimeC Composition
NeuroSense Therapeutics Announces Receipt of Nasdaq Notifications Regarding Minimum Bid Price and Market Value Requirements [Yahoo! Finance]
NeuroSense Therapeutics Announces Receipt of Nasdaq Notifications Regarding Minimum Bid Price and Market Value Requirements
Form 6-K NeuroSense Therapeutics For: Apr 06
Form 6-K NeuroSense Therapeutics For: Apr 03
Form 4 NeuroSense Therapeutics For: Mar 26 Filed by: Eisenberg Or
Form 3 NeuroSense Therapeutics For: Mar 18 Filed by: Eisenberg Or
Form 3 NeuroSense Therapeutics For: Mar 18 Filed by: Mandil-Levin Revital
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.